DAPA VILDA 10/100 SR combines two powerful diabetes medications: Dapagliflozin (10mg) and Vildagliptin SR (100mg). This combination is designed to help manage blood sugar levels in adults with type 2 diabetes mellitus, providing a dual mechanism of action to achieve optimal glycemic control.

How Does It Work?

Dapagliflozin:

• Mechanism: SGLT2 inhibitor
• Function: Inhibits the reabsorption of glucose in the kidneys, promoting glucose excretion through urine.

Vildagliptin SR:

• Mechanism: DPP-4 inhibitor
• Function: Increases incretin levels, which helps to regulate insulin production and decrease glucagon levels.

Uses of DAPA VILDA 10/100 SR

• Primary Use: Management of type 2 diabetes mellitus
• Combination Therapy: Used in conjunction with diet and exercise
• Blood Sugar Control: Helps in achieving target glycemic levels

What is DAPA VILDA 10/100 SR?

DAPA VILDA 10/100 SR is a prescription medication combining Dapagliflozin and Vildagliptin SR. It offers a synergistic effect for better blood sugar management in type 2 diabetes patients.

Side Effects

• Urinary tract infections
• Nasopharyngitis
• Hypoglycemia (low blood sugar)
• Dehydration
• Kidney issues
• Pancreatitis

Safety Information

• Contraindications: Not suitable for patients with type 1 diabetes or severe kidney impairment.
• Precautions: Regular monitoring of kidney function and hydration status is recommended.
• Interactions: Inform your doctor of all medications being taken to avoid potential interactions.

If You Need More Information About  DAPA VILDA 10/100 SR  Click here